Integrum

10.82 SEK

+3.64 %

Less than 1K followers

INTEG B

First North Stockholm

Medical Equipment & Services

Health Care

Overview

Financials & Estimates

Ownership

Investor consensus

+3.64 %

+29.84 %

-74.09 %

-45.75 %

-40.12 %

-45.75 %

-70.38 %

-64.42 %

-45.70 %

Integrum is active in medical technology. The company develops systems for skeletally anchored prostheses based on the developed OPRA implant system, which is later resold to hospitals worldwide. The implant is placed on the patient's leg with the help of titanium screws and is believed to improve the lives of a large number of patients with amputation. The company was founded in 1998 and has its headquarters in Mölndal.

Market cap

288.55M SEK

Turnover

1.16M SEK

Revenue

91.1M

EBIT %

-46.52 %

P/E

-

Dividend yield-%

-

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar

2.3

2026

Interim report Q3'26

4.6

2026

Annual report '26

All

Press releases

ShowingAll content types

Regulatory press release12/2/2025, 8:27 PM

Integrum AB: Integrum's rights issue oversubscribed

Regulatory press release11/21/2025, 6:00 AM

Integrum AB: Integrum publishes Interim Report for Q2 2025/26

Press release11/19/2025, 3:01 PM

Integrum AB: Invitation to the Second Quarter 2025/26 Results Presentation

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account

Followings and notifications on followed companies

Analyst comments and recommendations

Stock comparison tool & other popular tools

Press release11/18/2025, 3:12 PM

Integrum AB: The subscription period in Integrum's rights issue has begun

Regulatory press release11/14/2025, 7:00 AM

Integrum AB: Integrum publishes information document regarding rights issue

Regulatory press release11/13/2025, 4:56 PM

Integrum AB: Integrum publishes preliminary financial key figures for the second quarter 2025/26

Regulatory press release11/10/2025, 3:55 PM

Integrum AB: Integrum enters into bridge loan agreement to cover short-term working capital needs

Regulatory press release10/23/2025, 11:35 AM

Integrum AB: Integrum announces organizational restructuring to strengthen its commercial focus

Press release10/20/2025, 8:37 AM

Integrum AB: Integrum announces that the Swedish Securities Council has published a statement regarding the takeover offer for Integrum

Press release10/16/2025, 11:35 AM

DNB Carnegie Access: Integrum: Withdrawing fair value

Regulatory press release10/16/2025, 6:31 AM

Integrum AB: Integrum resolves on a rights issue of shares of series B of approximately SEK 42.6 million subject to approval by extraordinary general meeting and earlier release of Q2 report

Regulatory press release10/16/2025, 6:30 AM

Integrum AB: Integrum provides operational update ahead of Q2 report

Regulatory press release9/18/2025, 12:45 AM

Integrum AB: Integrum provides update on OsteoCentric's public offer and provides correction of previous announced information

Regulatory press release9/16/2025, 10:30 PM

Integrum AB: Integrum comments on OsteoCentric's announcement of outcome in the public offer

Press release9/16/2025, 5:59 AM

DNB Carnegie Access: Integrum: OsteoCentric offer fails to reach 90% threshold

Press release9/4/2025, 2:23 PM

Integrum AB: Integrum Unveils Global Marketing Strategy at AOPA National Assembly

Press release9/2/2025, 8:33 AM

Redeye: Integrum Q1 - Miss on sales

Regulatory press release9/1/2025, 11:16 AM

Integrum AB: Correction of Figures in Interim Report for the First Quarter 2025/26

Press release9/1/2025, 6:39 AM

DNB Carnegie Access: Integrum: Solid improvement continues – Q1(25/26) initial

Regulatory press release9/1/2025, 5:15 AM

Integrum AB: Stronger positioning paves the way for continued growth

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.